Log in
Enquire now
Hedera Dx

Hedera Dx

Hedera Dx is a blood-based cancer testing solutions provider founded in 2021 by Tommi Lehtonen, Damien Lapray and Christian Meisel.

OverviewStructured DataIssuesContributors

Contents

hederadx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Health technology
Health technology
Digital health
Digital health
Diagnosis
Diagnosis
Cancer
Cancer
Software as a service (SaaS)
Software as a service (SaaS)
Oncology
Oncology
Precision Oncology
Precision Oncology
B2X
B2B
B2B
CEO
Tommi Lehtonen
Tommi Lehtonen
Founder
Tommi Lehtonen
Tommi Lehtonen
‌
Damien Lapray
‌
Christian Meisel
Number of Employees (Ranges)
11 – 50
Email Address
care@hederadx.com
Investors
Helsana
Helsana
Inventure
Inventure
Tesi
Tesi
Eyrir
Eyrir
‌
Vsquared Ventures
‌
Top Harvest Capital
Founded Date
2021
Total Funding Amount (USD)
17,000,000
Latest Funding Round Date
May 27, 2025
Latest Funding Type
Series A
Series A
Country
Switzerland
Switzerland
Headquarters
Geneva
Geneva

Other attributes

Affiliated With
Biopôle SA
Biopôle SA
Latest Funding Round Amount (USD)
17,000,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Hedera Dx

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.